Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.7001
+0.0096 (1.39%)
At close: Aug 29, 2025, 4:00 PM
0.6866
-0.0135 (-1.93%)
After-hours: Aug 29, 2025, 4:02 PM EDT
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $35.42 million as of August 29, 2025. Its market cap has increased by 1.39% in one year.
Market Cap
35.42M
Enterprise Value
-78.20M
1-Year Change
1.39%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $35.42M, a decrease of -91.70%. That is a compound annual growth rate of -47.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 35.79M | -18.03% |
| Dec 31, 2024 | 43.66M | 188.36% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
| Oct 22, 2021 | 426.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 656.38B |
| Johnson & Johnson | 426.08B |
| AbbVie | 371.03B |
| UnitedHealth Group | 277.22B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 245.07B |
| Abbott Laboratories | 230.44B |